Screening of Pre-Term Babies through Neurosonography

Abstract

Brain maturation, the existence of structural brain abnormalities or brain damage, the timing of cerebral injury, and the neurological prognosis of the newborn are all things that may be determined with the use of NSG. It is crucial in determining whether or not to discontinue intense therapy in critically sick newborns and neonates with brain abnormalities who are expected to survive despite their damage. It may aid in optimizing care for the newborn and providing postnatal support for the newborn's family. Premature birth affects around 10% of all births; among these infants, more than 10% will suffer brain damage that cause severe developmental delays or disabilities such cerebral palsy, seizures, mental retardation, and learning problems. As a result, the purpose of the current research is to screen all of these children at risk of neurological difficulties, find structural abnormality, forecast neuro developmental outcome, advise the parents accordingly, and urge the family to conduct early intervention.